Articles tagged with "plaque psoriasis"

Risankizumab & Apremilast Come to Market in Canada

March 9, 2020 • By Michele B. Kaufman, PharmD, BCGP

Risankizumab Demonstrates Superiority to Secukinumab for Plaque Psoriasis

February 5, 2020 • By Michele B. Kaufman, PharmD, BCGP

Imagining a Life Free from the Pain of Ankylosing Spondylitis

September 30, 2019 • By Lara C. Pullen, PhD

FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications

May 29, 2019 • By Michele B. Kaufman, PharmD, BCGP

IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis

May 14, 2019 • By Michele B. Kaufman, PharmD, BCGP

Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol

May 7, 2019 • By Michele B. Kaufman, PharmD, BCGP

Mirikizumab Promising for Plaque Psoriasis

April 10, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review

December 3, 2018 • By Michele B. Kaufman, PharmD, BCGP

Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence

October 22, 2018 • By Michele B. Kaufman, PharmD, BCGP

Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab

October 9, 2018 • By Michele B. Kaufman, PharmD, BCGP

1
2
3
…
5
Next Page »